Integrated Weighted Gene Co-expression Network Analysis with an Application to Chronic Fatigue Syndrome

[1]  S. Horvath,et al.  A General Framework for Weighted Gene Co-Expression Network Analysis , 2005, Statistical applications in genetics and molecular biology.

[2]  Y. Leea,et al.  Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target , 2006 .

[3]  C. Pignata,et al.  Congenital Alopecia and nail dystrophy associated with severe functional T-cell immunodeficiency in two sibs. , 1996, American journal of medical genetics.

[4]  Aiqing He,et al.  Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids , 2006, Proceedings of the National Academy of Sciences.

[5]  B. Pedersen,et al.  [Chronic fatigue syndrome--a controlled cross-sectional study]. , 1994, Ugeskrift for laeger.

[6]  P. A. Kurup,et al.  HYPOTHALAMIC DIGOXIN, CEREBRAL CHEMICAL DOMINANCE AND MYALGIC ENCEPHALOMYELITIS , 2003, The International journal of neuroscience.

[7]  G. Kennedy,et al.  Increased neutrophil apoptosis in chronic fatigue syndrome , 2004, Journal of Clinical Pathology.

[8]  M. Ghoneum,et al.  Elevated apoptotic cell population in patients with chronic fatigue syndrome: the pivotal role of protein Kinase RNA , 1997, Journal of internal medicine.

[9]  David A. Schwartz,et al.  Loss-of-Function Mutation in Tryptophan Hydroxylase-2 Identified in Unipolar Major Depression , 2005, Neuron.

[10]  Jun Dong,et al.  Understanding network concepts in modules , 2007, BMC Systems Biology.

[11]  David Clayton,et al.  Epidemiological methods for studying genes and environmental factors in complex diseases , 2001, The Lancet.

[12]  Jun Dong,et al.  Geometric Interpretation of Gene Coexpression Network Analysis , 2008, PLoS Comput. Biol..

[13]  Steve Horvath,et al.  Using genetic markers to orient the edges in quantitative trait networks: The NEO software , 2008, BMC Systems Biology.

[14]  Hench Pk,et al.  Evaluation and differential diagnosis of fibromyalgia. Approach to diagnosis and management. , 1989, Rheumatic diseases clinics of North America.

[15]  S. Horvath,et al.  Evidence for anti-Burkitt tumour globulins in Burkitt tumour patients and healthy individuals. , 1967, British Journal of Cancer.

[16]  G. Chrousos,et al.  The three-way interactions between the hypothalamic-pituitary-adrenal and gonadal axes and the immune system. , 1996, Bailliere's clinical rheumatology.

[17]  William Bains,et al.  Treating Chronic Fatigue states as a disease of the regulation of energy metabolism. , 2008, Medical hypotheses.

[18]  Maria Bitner-Glindzicz,et al.  Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. , 2005, American journal of human genetics.

[19]  Chi V. Dang,et al.  The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Benjamin H. Natelson,et al.  Sub-typing CFS patients on the basis of ‘minor’ symptoms , 2006, Biological Psychology.

[21]  Joshua M. Stuart,et al.  A Gene-Coexpression Network for Global Discovery of Conserved Genetic Modules , 2003, Science.

[22]  Simona Lucioli,et al.  SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. , 2007, Brain : a journal of neurology.

[23]  Sue Goo Rhee,et al.  Peroxiredoxin III, a Mitochondrion-specific Peroxidase, Regulates Apoptotic Signaling by Mitochondria* , 2004, Journal of Biological Chemistry.

[24]  S. Flanagan,et al.  'Nude', a new hairless gene with pleiotropic effects in the mouse. , 1966, Genetical research.

[25]  W. Reeves,et al.  Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome , 2007, Genes, brain, and behavior.

[26]  Muin J Khoury,et al.  Mendelian randomisation: a new spin or real progress? , 2003, The Lancet.

[27]  J. Castle,et al.  An integrative genomics approach to infer causal associations between gene expression and disease , 2005, Nature Genetics.

[28]  Ian Hickie,et al.  Prevalence of chronic fatigue syndrome in an Australian population , 1990, The Medical journal of Australia.

[29]  David C Hoaglin,et al.  Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. , 2003, Archives of internal medicine.

[30]  S. Horvath,et al.  Weighted gene coexpression network analysis strategies applied to mouse weight , 2007, Mammalian Genome.

[31]  H. Zhang,et al.  Enterovirus related metabolic myopathy: a postviral fatigue syndrome , 2003, Journal of neurology, neurosurgery, and psychiatry.

[32]  Eric Aslakson,et al.  Polymorphisms in genes regulating the HPA axis associated with empirically delineated classes of unexplained chronic fatigue. , 2006, Pharmacogenomics.

[33]  Paul Kellam,et al.  Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. , 2008, The Journal of infectious diseases.

[34]  S. Horvath,et al.  Conservation and evolution of gene coexpression networks in human and chimpanzee brains , 2006, Proceedings of the National Academy of Sciences.

[35]  I. Hickie,et al.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. , 1994, Annals of internal medicine.

[36]  Linqi Zhou,et al.  The effects of protein interactions, gene essentiality and regulatory regions on expression variation , 2008, BMC Systems Biology.

[37]  Korbinian Strimmer,et al.  From correlation to causation networks: a simple approximate learning algorithm and its application to high-dimensional plant gene expression data , 2007, BMC Systems Biology.

[38]  E. M. Pantelouris,et al.  The lymphoid tissues in mice with congenital aplasia of the thymus. , 1969, Clinical and experimental immunology.

[39]  E. M. Pantelouris,et al.  Absence of Thymus in a Mouse Mutant , 1968, Nature.

[40]  M. B. Katan,et al.  Apolipoprotein E isoforms, serum cholesterol, and cancer , 2004 .

[41]  S T Holgate,et al.  Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome , 2005, Journal of Clinical Pathology.

[42]  Rosane Nisenbaum,et al.  Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome , 2003, Journal of Translational Medicine.

[43]  Ian Hickie,et al.  The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.

[44]  N. Klimas,et al.  Chronic fatigue syndrome: Inflammation, immune function, and neuroendocrine interactions , 2007, Current rheumatology reports.

[45]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  A. Barabasi,et al.  Hierarchical Organization of Modularity in Metabolic Networks , 2002, Science.

[47]  Rosane Nisenbaum,et al.  Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution , 2003, BMC health services research.

[48]  Suzanne D Vernon,et al.  The challenge of integrating disparate high-content data: epidemiological, clinical and laboratory data collected during an in-hospital study of chronic fatigue syndrome. , 2006, Pharmacogenomics.

[49]  P. Pinsky,et al.  A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? , 1987, JAMA.

[50]  Andy M. Yip,et al.  Gene network interconnectedness and the generalized topological overlap measure , 2007, BMC Bioinformatics.

[51]  Cassio Pennachin,et al.  Combinations of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome. , 2006, Pharmacogenomics.

[52]  Elias Chaibub Neto,et al.  Genetic Networks of Liver Metabolism Revealed by Integration of Metabolic and Transcriptional Profiling , 2008, PLoS genetics.

[53]  B. Yandell,et al.  Inferring Causal Phenotype Networks From Segregating Populations , 2008, Genetics.

[54]  S. Kaasa,et al.  Hodgkin's disease: quality of life in future trials. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[55]  F. Fusco,et al.  Ancestral Founder Mutation of the Nude (FOXN1) Gene in Congenital Severe Combined Immunodeficiency Associated with Alopecia in Southern Italy Population , 2004, Annals of human genetics.

[56]  Michael Bader,et al.  Synthesis of Serotonin by a Second Tryptophan Hydroxylase Isoform , 2003, Science.

[57]  H. Stefánsson,et al.  Genetics of gene expression and its effect on disease , 2008, Nature.

[58]  S. Ebrahim,et al.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.

[59]  Keith Shockley,et al.  Structural Model Analysis of Multiple Quantitative Traits , 2006, PLoS genetics.

[60]  S C Gandevia,et al.  Muscle performance, voluntary activation, twitch properties and perceived effort in normal subjects and patients with the chronic fatigue syndrome. , 1991, Brain : a journal of neurology.

[61]  James F. Jones,et al.  Chronic Fatigue Syndrome – A clinically empirical approach to its definition and study , 2005, BMC medicine.

[62]  S. Horvath,et al.  Variations in DNA elucidate molecular networks that cause disease , 2008, Nature.

[63]  Leonard M. Freeman,et al.  A set of measures of centrality based upon betweenness , 1977 .

[64]  A. Loraine,et al.  Transcriptional Coordination of the Metabolic Network in Arabidopsis1[W][OA] , 2006, Plant Physiology.

[65]  Grace S. Shieh,et al.  Inferring transcriptional compensation interactions in yeast via stepwise structure equation modeling , 2008, BMC Bioinformatics.

[66]  Andrew H. Miller,et al.  Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. , 2005, Viral immunology.

[67]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[68]  R. Patarca,et al.  Cytokines and Chronic Fatigue Syndrome , 2001, Annals of the New York Academy of Sciences.

[69]  Steve Horvath,et al.  Network neighborhood analysis with the multi-node topological overlap measure , 2007, Bioinform..

[70]  Mangalathu S. Rajeevan,et al.  Genetic evaluation of the serotonergic system in chronic fatigue syndrome , 2008, Psychoneuroendocrinology.

[71]  P K Hench.  Evaluation and differential diagnosis of fibromyalgia. Approach to diagnosis and management. , 1989, Rheumatic diseases clinics of North America.